Src-ND2 interaction inhibitors (NoNO)

N/A

Report date: 2025/03/20 14:44:20
NME

Base Information

Drug NameSrc-ND2 interaction inhibitors (NoNO)
Drug Alias Namesrc-NADH dehydrogenase subunit 2 interaction inhibitors (NoNO)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADH dehydrogenase inhibitorsTyrosine-protein kinase SRC modulators
TargetsTyrosine-protein kinase SRCNADH dehydrogenase
Therapy Area/IndicationsInflammationNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNono Inc
China Registration ClassN/A

Develop Information

Active CompaniesNono Inc
Inactive CompaniesN/A
Active IndicationsInflammationNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A